PACIFIC: A Double-Blind, Placebo-Controlled Phase 3 Study of Durvalumab as Consolidation Therapy After Chemoradiation in Patients with Locally Advanced, Unresectable Non-Small Cell Lung Cancer Meeting Abstract

Industry Collaboration International Collaboration

cited authors

  • Antonia, S. J.; Villegas, A.; Daniel, D.; Baz, D. Vincente; Murakami, S.; Hui, R.; Yokoi, T.; Chiappori, A.; Lee, K. H.; de Wit, M.; Cho, B. C.; Bourhaba, M.; Quantin, X.; Tokito, T.; Mekhail, T.; Planchard, D.; Jiang, H.; Huang, Y.; Dennis, P. A.; Ozguroglu, M.

authors

Publication Date

  • December 1, 2017

webpage

published in

category

start page

  • 1314

end page

  • 1315

volume

  • 99

issue

  • 5